<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38641935</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1442-200X</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Season>Jan-Dec</Season></PubDate></JournalIssue><Title>Pediatrics international : official journal of the Japan Pediatric Society</Title><ISOAbbreviation>Pediatr Int</ISOAbbreviation></Journal><ArticleTitle>Severe acute respiratory syndrome coronavirus 2 infection rate among pediatric patients with respiratory symptoms.</ArticleTitle><Pagination><StartPage>e15740</StartPage><MedlinePgn>e15740</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ped.15740</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The incidence of coronavirus disease 2019 (COVID-19) in children has been increasing worldwide since the onset of the pandemic. This study examined the risk factors and characteristics of COVID-19 among pediatric patients compared to other respiratory viral infections.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a prospective cross-sectional study. Patients aged 0-18&#x2009;years presenting with respiratory symptoms from October 2020 to December 2021 were included. Demographic and clinical data were reviewed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 738 pediatric patients were enrolled. Of these, 48.5% had COVID-19, and 41.3% were infected with another respiratory virus. The COVID-19 incidence increased from 0.5% during the original strain outbreak (October 2020 to March 2021) to 56.5% and 73.4% during the alpha (April to June 2021) and delta (July to December 2021) periods, respectively. Children aged 6-18 years, being female, obesity, exposure to household members with COVID-19, and the delta period were risk factors for COVID-19. Being aged 1-5 years, obesity, shortness of breath, productive cough, and chest pain were associated with COVID-19 pneumonia. Children aged 5-18&#x2009;years, underlying neurological disease, a history of COVID-19 pneumonia, and the delta period were associated with long COVID.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Pediatric COVID-19 patients presenting with respiratory symptoms who are obese or have been exposed to household members with COVID-19 should be tested for COVID-19. COVID-19 patients who are obese, younger than five years old, or who present with shortness of breath, productive cough, or chest pain should be evaluated for pneumonia. COVID-19 patients with a history of COVID-19 pneumonia or underlying neurological disease should receive follow-up for long COVID.</AbstractText><CopyrightInformation>&#xa9; 2024 Japan Pediatric Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Samerton</LastName><ForeName>Penpitcha</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Srinagarind Hospital, Khon Kaen University, Khon Kaen, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Apiwattanakul</LastName><ForeName>Nopporn</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-1833-5127</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assawawiroonhakarn</LastName><ForeName>Surapat</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakan, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahakijpicharn</LastName><ForeName>Thiantip</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thongchai</LastName><ForeName>Rakruthai</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Techasaensiri</LastName><ForeName>Chonnamet</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boonsathorn</LastName><ForeName>Sophida</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6027-0534</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaisavaneeyakorn</LastName><ForeName>Sujittra</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8166-8691</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RF_64011</GrantID><Agency>Mahidol University</Agency><Country/></Grant><Grant><GrantID>P2050966</GrantID><Agency>National Science and Technology Development Agency</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Pediatr Int</MedlineTA><NlmUniqueID>100886002</NlmUniqueID><ISSNLinking>1328-8067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002637" MajorTopicYN="N">Chest Pain</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID&#x2010;19</Keyword><Keyword MajorTopicYN="N">SARS&#x2010;CoV&#x2010;2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">pediatric patients</Keyword><Keyword MajorTopicYN="N">respiratory symptoms</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>20</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>20</Day><Hour>4</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38641935</ArticleId><ArticleId IdType="doi">10.1111/ped.15740</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>World Health Organization. WHO director&#x2010;general's opening remarks at the media briefing on COVID&#x2010;19. 2020 Available from: https://www.who.int/director&#x2010;general/speeches/detail/who&#x2010;director&#x2010;general&#x2010;s&#x2010;opening&#x2010;remarks&#x2010;at&#x2010;the&#x2010;media&#x2010;briefing&#x2010;on&#x2010;covid&#x2010;19&#x2010;&#x2010;&#x2010;11&#x2010;march&#x2010;2020</Citation></Reference><Reference><Citation>World Health Organization. COVID&#x2010;19 Weekly Epidemiological Update. 2022 Available from: https://www.who.int/docs/default&#x2010;source/coronaviruse/situation&#x2010;reports/20220222_weekly_epi_update_80.pdf</Citation></Reference><Reference><Citation>Araf Y, Akter F, Tang YD, Fatemi R, Parvez MSA, Zheng C, et&#xa0;al. Omicron variant of SARS&#x2010;CoV&#x2010;2: genomics, transmissibility, and responses to current COVID&#x2010;19 vaccines. J Med Virol. 2022;94(5):1825&#x2013;1832.</Citation></Reference><Reference><Citation>Choi JY, Smith DM. SARS&#x2010;CoV&#x2010;2 variants of concern. Yonsei Med J. 2021;62(11):961&#x2013;968.</Citation></Reference><Reference><Citation>Tao K, Tzou PL, Nouhin J, Gupta RK, de Oliveira T, Kosakovsky Pond SL, et&#xa0;al. The biological and clinical significance of emerging SARS&#x2010;CoV&#x2010;2 variants. Nat Rev Genet. 2021;22(12):757&#x2013;773.</Citation></Reference><Reference><Citation>Ministry of Public Health, Thailand. Available from: https://ddc.moph.go.th/covid19&#x2010;dashboard/.</Citation></Reference><Reference><Citation>Department of Disease Control. Open Government Data of Thailand. Available from: https://data.go.th/dataset/covid&#x2010;19&#x2010;daily</Citation></Reference><Reference><Citation>de Souza TH, Nadal JA, Nogueira RJN, Pereira RM, Brandao MB. Clinical manifestations of children with COVID&#x2010;19: a systematic review. Pediatr Pulmonol. 2020;55(8):1892&#x2013;1899.</Citation></Reference><Reference><Citation>Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, et&#xa0;al. American College of Rheumatology Clinical Guidance for multisystem inflammatory syndrome in children associated with SARS&#x2010;CoV&#x2010;2 and hyperinflammation in pediatric COVID&#x2010;19: version 3. Arthritis Rheumatol. 2022;74(4):e1&#x2013;e20.</Citation></Reference><Reference><Citation>Department of Disease Control MoPH, Thailand. Case definition for patients under investigation (PUIs) with COVID&#x2010;19. 2020 Available from: https://ddc.moph.go.th/viralpneumonia/eng/file/guidelines/G_PUIdefinition.pdf</Citation></Reference><Reference><Citation>SARS&#x2010;CoV&#x2010;2 variants in Thailand Available from: https://drive.google.com/drive/folders/13k14Hs61pgrK8raSMS9LFQn83PKswS&#x2010;b.</Citation></Reference><Reference><Citation>COVID&#x2010;19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID&#x2010;19) Treatment Guidelines. National Institutes of Health. Available from: https://www.covid19treatmentguidelines.nih.gov/</Citation></Reference><Reference><Citation>Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et&#xa0;al. Epidemiology of COVID&#x2010;19 among children in China. Pediatrics. 2020;145(6):e20200702.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. Information for healthcare providers about multisystem inflammatory syndrome in children (MIS&#x2010;C). 2021 Available from: https://www.cdc.gov/mis/mis&#x2010;c/hcp/index.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fmis%2Fhcp%2Findex.html</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. Post&#x2010;covid conditions: Information for healthcare providers. 2021 Available from: https://www.cdc.gov/coronavirus/2019&#x2010;ncov/hcp/clinical&#x2010;care/post&#x2010;covid&#x2010;conditions.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019&#x2010;ncov%2Fhcp%2Fclinical&#x2010;care%2Flate&#x2010;sequelae.html</Citation></Reference><Reference><Citation>WHO. WHO AnthroPlus for personal computers Manual: Software for assessing growth of the world's children and adolescents Geneva. 2009 Available from: https://www.who.int/tools/growth&#x2010;reference&#x2010;datafor&#x2010;5to19&#x2010;years</Citation></Reference><Reference><Citation>Cai X, Jiang H, Zhang S, Xia S, Du W, Ma Y, et&#xa0;al. Clinical manifestations and pathogen characteristics in children admitted for suspected COVID&#x2010;19. Front Med. 2020;14(6):776&#x2013;785.</Citation></Reference><Reference><Citation>Leuzinger K, Roloff T, Gosert R, Sogaard K, Naegele K, Rentsch K, et&#xa0;al. Epidemiology of severe acute respiratory syndrome coronavirus 2 emergence amidst community&#x2010;acquired respiratory viruses. J Infect Dis. 2020;222(8):1270&#x2013;1279.</Citation></Reference><Reference><Citation>Yang W, Shaman J. Development of a model&#x2010;inference system for estimating epidemiological characteristics of SARS&#x2010;CoV&#x2010;2 variants of concern. Nat Commun. 2021;12(1):5573.</Citation></Reference><Reference><Citation>Abo YN, Clifford V, Lee LY, Costa AM, Crawford N, Wurzel D, et&#xa0;al. COVID&#x2010;19 public health measures and respiratory viruses in children in Melbourne. J Paediatr Child Health. 2021;57(12):1886&#x2013;1892.</Citation></Reference><Reference><Citation>Di Mattia G, Nenna R, Mancino E, Rizzo V, Pierangeli A, Villani A, et&#xa0;al. During the COVID&#x2010;19 pandemic where has respiratory syncytial virus gone? Pediatr Pulmonol. 2021;56(10):3106&#x2013;3109.</Citation></Reference><Reference><Citation>Haapanen M, Renko M, Artama M, Kuitunen I. The impact of the lockdown and the re&#x2010;opening of schools and day cares on the epidemiology of SARS&#x2010;CoV&#x2010;2 and other respiratory infections in children &#x2010; a nationwide register study in Finland. EClinicalMedicine. 2021;34:100807.</Citation></Reference><Reference><Citation>Huete&#x2010;Perez JA, Ernst KC, Cabezas&#x2010;Robelo C, Paiz&#x2010;Medina L, Silva S, Huete A. Prevalence and risk factors for SARS&#x2010;CoV&#x2010;2 infection in children with and without symptoms seeking care in Managua, Nicaragua: results of a cross&#x2010;sectional survey. BMJ Open. 2021;11(9):e051836.</Citation></Reference><Reference><Citation>Anugulruengkitt S, Teeraananchai S, Chantasrisawad N, Promsena P, Jantarabenjakul W, Puthanakit T. Clinical outcomes of pediatric COVID&#x2010;19 in a tertiary care center in Bangkok. Thailand IJID Reg. 2021;1:159&#x2013;162.</Citation></Reference><Reference><Citation>Wuttayakorn T, Sithisarankul P. Risk factors for COVID&#x2010;19 infection. J Prev Med Assoc Thailand. 2021;11(2):447&#x2013;464.</Citation></Reference><Reference><Citation>Bruminhent J, Ruangsubvilai N, Nabhindhakara J, Ingsathit A, Kiertiburanakul S. Clinical characteristics and risk factors for coronavirus disease 2019 (COVID&#x2010;19) among patients under investigation in Thailand. PloS One. 2020;15(9):e0239250.</Citation></Reference><Reference><Citation>Zhang JJ, Dong X, Liu GH, Gao YD. Risk and protective factors for COVID&#x2010;19 morbidity, severity, and mortality. Clin Rev Allergy Immunol. 2022;64:90&#x2013;107.</Citation></Reference><Reference><Citation>Zhang ZZ, Chen DP, Liu QB, Gan C, Jiang L, Zhu K, et&#xa0;al. Clinical features of Chinese children with COVID&#x2010;19 and other viral respiratory infections. Pediatr Pulmonol. 2022;57(1):49&#x2013;56.</Citation></Reference><Reference><Citation>Guo L, Gonzalez R, Xie Z, Zhou H, Liu C, Wu C, et&#xa0;al. Bocavirus in children with respiratory tract infections. Emerg Infect Dis. 2011;17(9):1775&#x2013;1777.</Citation></Reference><Reference><Citation>Karalar L, Lindner J, Schimanski S, Kertai M, Segerer H, Modrow S. Prevalence and clinical aspects of human bocavirus infection in children. Clin Microbiol Infect. 2010;16(6):633&#x2013;639.</Citation></Reference><Reference><Citation>Molteni E, Sudre CH, Canas LDS, Bhopal SS, Hughes RC, Chen L, et&#xa0;al. Illness characteristics of COVID&#x2010;19 in children infected with the SARS&#x2010;CoV&#x2010;2 Delta variant. Children (Basel). 2022;9(5):652.</Citation></Reference><Reference><Citation>Shi Q, Wang Z, Liu J, Wang X, Zhou Q, Li Q, et&#xa0;al. Risk factors for poor prognosis in children and adolescents with COVID&#x2010;19: a systematic review and meta&#x2010;analysis. EClinicalMedicine. 2021;41:101155.</Citation></Reference><Reference><Citation>Pazukhina E, Andreeva M, Spiridonova E, Bobkova P, Shikhaleva A, El&#x2010;Taravi Y, et&#xa0;al. Prevalence and risk factors of post&#x2010;COVID&#x2010;19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID). BMC Med. 2022;20(1):244.</Citation></Reference><Reference><Citation>Tang Z, Li M, Chen W, Ran X, Li H, Chen Z. Clinical symptoms of COVID&#x2010;19 pneumonia in children: a protocol for systematic review and meta&#x2010;analysis. Medicine (Baltimore). 2021;100(1):e24108.</Citation></Reference><Reference><Citation>Fainardi V, Meoli A, Chiopris G, Motta M, Skenderaj K, Grandinetti R, et&#xa0;al. Long COVID in children and adolescents. Life (Basel). 2022;12(2):285.</Citation></Reference><Reference><Citation>Irfan O, Li J, Tang K, Wang Z, Bhutta ZA. Risk of infection and transmission of SARS&#x2010;CoV&#x2010;2 among children and adolescents in households, communities and educational settings: a systematic review and meta&#x2010;analysis. J Glob Health. 2021;11:05013.</Citation></Reference><Reference><Citation>Yong SJ. Long COVID or post&#x2010;COVID&#x2010;19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021;53(10):737&#x2013;754.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>